Feed Insights Top Reports Pricing

⌘K

16:02:13·1039d

SECFilingvia Quantisnow

SEC Form 10-Q filed by OP Bancorp

ByQuantisnow·Wall Street's wire, on your screen.

OPBK· OP Bancorp

Finance

Plus alert sent

Quantisnow Plus members were alerted at 16:02:13 ET - 0.7s after publication.

Sign up for Plus

Free Quantisnow account

Get notified the moment OPBK files

Real-time alerts on SEC filings, FDA approvals, analyst ratings, insider trades, and press releases. Follow any ticker. No credit card.

Sign up free Log in

Original source

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OPBK (OP Bancorp) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

Chief Operating Officer Oh Christine Yoon sold $309,928 worth of shares (21,818 units at $14.21), decreasing direct ownership by 15% to 120,788 units (SEC Form 4)
SEC Form 144 filed by OP Bancorp
Chief Risk Officer Park Jae H. converted options into 3,846 shares and covered exercise/tax liability with 1,241 shares, increasing direct ownership by 34% to 10,298 units (SEC Form 4)
Director Yoon Ki Won converted options into 2,408 shares, increasing direct ownership by 5% to 52,818 units (SEC Form 4)
Director Sohn Myung Shin converted options into 2,408 shares, increasing direct ownership by 16% to 17,034 units (SEC Form 4)

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022